CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 230 filers reported holding CORCEPT THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.39 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,125,577 | +9.0% | 371,649 | -11.0% | 0.00% | 0.0% |
| Q2 2023 | $9,288,151 | +92.8% | 417,445 | +87.7% | 0.00% | +100.0% |
| Q1 2023 | $4,816,296 | -24.4% | 222,359 | -29.1% | 0.00% | 0.0% |
| Q4 2022 | $6,368,119 | -36.0% | 313,546 | -19.2% | 0.00% | -50.0% |
| Q3 2022 | $9,947,000 | +75.8% | 387,960 | +63.1% | 0.00% | +100.0% |
| Q2 2022 | $5,657,000 | -8.3% | 237,867 | -13.1% | 0.00% | 0.0% |
| Q1 2022 | $6,166,000 | +244.1% | 273,833 | +202.6% | 0.00% | – |
| Q4 2021 | $1,792,000 | -35.4% | 90,500 | -35.8% | 0.00% | – |
| Q3 2021 | $2,772,000 | -26.3% | 140,900 | -17.5% | 0.00% | -100.0% |
| Q2 2021 | $3,759,000 | -27.5% | 170,818 | -21.7% | 0.00% | 0.0% |
| Q1 2021 | $5,188,000 | -57.0% | 218,061 | -52.8% | 0.00% | -66.7% |
| Q4 2020 | $12,078,000 | +140.5% | 461,686 | +60.0% | 0.00% | +200.0% |
| Q3 2020 | $5,022,000 | -20.0% | 288,529 | -22.6% | 0.00% | -50.0% |
| Q2 2020 | $6,274,000 | -23.1% | 372,978 | -45.7% | 0.00% | -50.0% |
| Q1 2020 | $8,161,000 | -43.0% | 686,395 | -42.0% | 0.00% | -33.3% |
| Q4 2019 | $14,325,000 | +23.8% | 1,183,858 | +44.6% | 0.01% | +20.0% |
| Q3 2019 | $11,575,000 | -8.6% | 818,953 | -27.9% | 0.01% | 0.0% |
| Q2 2019 | $12,658,000 | +180.9% | 1,135,266 | +195.7% | 0.01% | +66.7% |
| Q1 2019 | $4,507,000 | -9.4% | 383,966 | +3.1% | 0.00% | +50.0% |
| Q4 2018 | $4,977,000 | +134.8% | 372,554 | +146.4% | 0.00% | – |
| Q3 2018 | $2,120,000 | -33.2% | 151,194 | -25.2% | 0.00% | -100.0% |
| Q2 2018 | $3,176,000 | -43.6% | 202,084 | -41.0% | 0.00% | -33.3% |
| Q1 2018 | $5,634,000 | +125.4% | 342,449 | +147.5% | 0.00% | +50.0% |
| Q4 2017 | $2,500,000 | -35.4% | 138,376 | -31.0% | 0.00% | -33.3% |
| Q3 2017 | $3,872,000 | +65.0% | 200,636 | +0.9% | 0.00% | +50.0% |
| Q2 2017 | $2,347,000 | +145.8% | 198,894 | +128.4% | 0.00% | +100.0% |
| Q1 2017 | $955,000 | +93.7% | 87,094 | +28.2% | 0.00% | – |
| Q4 2016 | $493,000 | +102.0% | 67,916 | +80.8% | 0.00% | – |
| Q3 2016 | $244,000 | +216.9% | 37,565 | +129.7% | 0.00% | – |
| Q1 2016 | $77,000 | -44.2% | 16,351 | -40.8% | 0.00% | – |
| Q4 2015 | $138,000 | -69.5% | 27,620 | -77.1% | 0.00% | – |
| Q3 2015 | $453,000 | +738.9% | 120,350 | +1229.4% | 0.00% | – |
| Q2 2015 | $54,000 | -28.0% | 9,053 | -32.2% | 0.00% | – |
| Q1 2015 | $75,000 | +10.3% | 13,344 | -44.7% | 0.00% | – |
| Q2 2014 | $68,000 | +36.0% | 24,117 | +109.0% | 0.00% | – |
| Q1 2014 | $50,000 | – | 11,539 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 6,825,262 | $138,621 | 7.54% |
| Novo Holdings A/S | 3,377,768 | $68,602,468 | 4.28% |
| Parallel Advisors, LLC | 3,724,664 | $75,647,926 | 3.28% |
| TANAKA CAPITAL MANAGEMENT INC | 35,539 | $722 | 2.29% |
| Quantedge Capital Pte Ltd | 251,312 | $5,104,147 | 1.71% |
| S&T BANK/PA | 346,306 | $7,033 | 1.30% |
| Freshford Capital Management, LLC | 249,000 | $5,057,190 | 1.09% |
| Birchview Capital, LP | 50,000 | $1,016 | 0.72% |
| FAS Wealth Partners, Inc. | 306,276 | $6,220,466 | 0.70% |
| Bridge City Capital, LLC | 60,824 | $1,235 | 0.63% |